Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.
about
Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Type II RAF inhibitor causes s ...... urrently found in lung cancer.
@en
Type II RAF inhibitor causes s ...... urrently found in lung cancer.
@nl
type
label
Type II RAF inhibitor causes s ...... urrently found in lung cancer.
@en
Type II RAF inhibitor causes s ...... urrently found in lung cancer.
@nl
prefLabel
Type II RAF inhibitor causes s ...... urrently found in lung cancer.
@en
Type II RAF inhibitor causes s ...... urrently found in lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Type II RAF inhibitor causes s ...... currently found in lung cancer
@en
P2093
Amir Noeparast
Erik Teugels
Jacques De Grève
Sylvia De Brakeleer
Ulrike De Ridder
P2860
P304
16110-16123
P356
10.18632/ONCOTARGET.24576
P407
P577
2018-02-27T00:00:00Z